Management of acute self-limited pain in patients in a health center
DOI:
https://doi.org/10.32385/rpmgf.v24i4.10526Keywords:
Pain epidemiology, Frequency, Acute pain, Self-medicationAbstract
Introduction: The treatment of pain is a capacity shared by the physician and the patients.Well-informed self-medication is beneficial for the population and for the Health System; however, frequent mistakes add to the risk of adverse effects. Goals: To depict the self-limited episodes of acute pain and the respective therapeutic management featured in the examined sampling. To study the self-medication cases in terms of frequency and connection with socio-demographic factors. Methods: The cross-sectional study was based on a sampling of 352 patients from the Cacém Health Care Centre (Olival extension), using one questionnaire for each of the personal interviews concerning self-limited acute pain and its therapeutic management during the 30 preceding days. Results: There were 89 episodes of self-limited acute pain (25.3%), mainly women. The most frequent episodes consisted of headaches (48.3%),myalgia and flu syndrome-related headaches (10.1%) and rachialgia (7.9%). Of the 89 patients that referred an episode of self-limited acute pain in the 30 days prior to the questionnaire, 63.0% relied solely on pharmacotherapy, while 12.4% resorted to non-pharmacological therapeutic as well. The most widely used drugs were Paracatemol (50.7%) and NSAIDs (31.3%). Self-medication was frequent (46.5%), mostly on women of less than 45 years of age; it was associated with sub-therapeutic drugs and was based on prior medical indication or self-decision. Discussion: It was observed that there are significant associations between self-medication and a few socio-demographic factors and that self-medication hinders an adequate posology.The importance of self-decision in the context of self-medication was also noted; the study suggests that the patients must be better clarified about the properties of the drugs.Downloads
Downloads
Published
Issue
Section
License
The authors will assign to the RPMGF the sole right to publish and distribute the content of the manuscript specified in this declaration via physical, electronic, broadcasting or any other medium that may come into existence. They also grant the RPMGF the right to use and exploit this manuscript, in particular by assigning, selling or licensing its content. This permission is permanent and takes effect from the moment the manuscript is submitted, has the maximum duration allowed by applicable Portuguese or international law and is of worldwide scope. The authors further declare that this assignment is made free of charge. If the RPMGF informs the authors that it is not going to publish their manuscript, the exclusive assignment of rights ceases forthwith.
The authors authorise the RPMGF (or any entity it may appoint) to act on their behalf when it believes that copyright may have been infringed.